Replimune REPL
NASDAQ REPL
$15.01 -0.28 (-1.83%)
As of: Sep 4, 2026 · 2:22 PM EDT

Replimune (REPL) Interest Expenses (2019 - 2026)

Replimune (REPL) posted Interest Expenses of $3.6 million for Q1 2026, down 91.3% sequentially from $41.6 million in Q4 2025, and up 3221.55% YoY from $109015.3 in Q1 2025.

Analysis

Replimune (REPL) Interest Expenses (2019 - 2026) Analysis & Trends

Replimune has reported Interest Expenses for 10 years, with the latest figure at $3.6 million in Q1 2026.

  • Quarterly Interest Expenses rose 3221.55% year-over-year to $3.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.9 million (up 95.01% YoY) and the FY2026 annual result came in at $312.0 million, up 40.79% from the prior year.
  • Interest Expenses fell to $3.6 million in Q1 2026 per REPL's latest filing, from $41.6 million in the prior quarter.
  • Over five years, Interest Expenses peaked at $51.0 million in Q2 2022 and troughed at -$242000.0 in Q1 2022.
  • A 5-year average of $33.2 million and a median of $44.4 million in 2024 frame the typical range for Interest Expenses.
  • The sharpest annual moves came in 2022 and 2026: Interest Expenses tumbled 232.97% in 2022, then soared 3221.55% in 2026.
  • Over 5 years, Interest Expenses stood at $49.7 million in 2022, then declined by 5.27% to $47.1 million in 2023, then slipped by 5.73% to $44.4 million in 2024, then dropped by 6.26% to $41.6 million in 2025, then plunged by 91.3% to $3.6 million in 2026.
  • According to Business Quant data, Interest Expenses over the past three periods registered $3.6 million, $41.6 million, and $42.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Expense (Qtr)
1 Vertex Pharmaceuticals 138.87 Bn 131.01 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.57 Bn 77.57 Bn 3.93 Bn 11.00 Mn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn -1.00 Mn
4 Moderna 58.19 Bn 53.05 Bn 52.00 Mn -
5 Revolution Medicines 44.07 Bn 44.07 Bn - 23.78 Mn
6 BeOne Medicines 39.99 Bn 34.89 Bn 1.53 Bn 39.74 Mn
7 Alnylam Pharmaceuticals 35.38 Bn 32.07 Bn 992.69 Mn 82.05 Mn
8 Royalty Pharma 28.42 Bn 27.58 Bn - 93.62 Mn
9 Insmed 27.41 Bn 26.25 Bn 358.27 Mn 20.27 Mn
10 Replimune 1.45 Bn 1.45 Bn - 2.58 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.58 Mn
Mar 31, 2026 2.37 Mn
Dec 31, 2025 1.47 Mn
Sep 30, 2025 1.49 Mn
Jun 30, 2025 1.48 Mn
Mar 31, 2025 1.46 Mn
Dec 31, 2024 1.45 Mn
Sep 30, 2024 1.44 Mn
Jun 30, 2024 1.43 Mn
Mar 31, 2024 1.41 Mn
Dec 31, 2023 1.01 Mn
Sep 30, 2023 955,000.00
Jun 30, 2023 1.12 Mn
Mar 31, 2023 1.02 Mn
Dec 31, 2022 941,000.00
Mar 31, 2021 1,000.00
Dec 31, 2020 247,000.00
Sep 30, 2020 286,000.00
Jun 30, 2020 284,000.00
Mar 31, 2020 -295,000.00